Module 5: Rare primary CNS tumors in children and adults

Chairs: Roberta Rudà (Italy), Filip De Vos (Netherlands), Peter Hau (Germany)

Note that the programme is subject to change and will be continuously updated.
All times below refer to Central European Time (CET).

Saturday, November 4, 2023

10:00 - 10:45
M5.01 Molecular pathology of ependymomas and medulloblastomas
Felix Sahm, Germany


11:00 - 11:45
M5.02 Surgical therapy in ependymomas and medulloblastomas
Luca Regli, Switzerland


12:00 - 12:45
M5.03 Multimodal therapies for ependymomas and medulloblastomas
Peter Hau, Germany


12:45 - 13:45
Lunch Break


13:45 - 14:30
M5.04 Neuroimaging of rare brain tumors
tbc


14:45 - 15:30
M5.05 When and how radiotherapy has indication?
Frederic Dhermain, France

 

 

Sunday, November 5, 2023

10:00 - 10:45
M5.06 Molecular pathology of rare circumscribed gliomas and glioneuronal tumors
tbc


11:00 - 11:45
M5.07 Surgical therapy for rare circumscribed gliomas and glioneuronal tumors: oncological and epileptological value
Johan Pallud, France


12:00 - 12:45
M5.08 Multimodal therapies for rare circumscribed gliomas and glioneuronal tumors: case discussion
Roberta Rudà, Italy


12:45 - 13:45
Lunch Break


13:45 - 14:30
M5.09 Pineal and very rare tumors
Evangelia Razis, Greece


14:45 - 15:30
M5.10 New trial design and concepts for rare tumor
Mark Gilbert, United States


15:30 - 16:30
Test

CME credits

The European Association of Neuro-Oncology (EANO) will be seeking accreditation from the European Accreditation Council of Continuing Medical Education.